Showing results (441-450 of 875) with videos related to
Sort By:
Pageof 88
Journal of the American Academy of Nurse Practitioners|January 16, 2010
Anemia and its impact on function in nursing home residents: what do we know?Valerie K Sabol, Barbara Resnick, Elizabeth Galik, et al.British Journal of Pharmacology|September 1, 1992
Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openersK Lawson, M Barras, E Zazzi-Sudriez, et al.Osteoarthritis and Cartilage|August 6, 2016
The association of waist circumference with walking difficulty among adults with or at risk of knee osteoarthritis: the Osteoarthritis InitiativeS V Gill, G E Hicks, Y Zhang, et al.Journal of Digital Imaging|August 19, 2010
Early experience using an online reporting system for interventional radiology procedure-related complications integrated with a digital dictation systemSanjay Gupta, Jay Patel, Kevin McEnery, et al.Journal of Vascular and Interventional Radiology : JVIR|December 7, 2007
Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumabRavi Murthy, Cathy Eng, Sunil Krishnan, et al.Journal of Vascular and Interventional Radiology : JVIR|January 1, 1994
Interventional radiologic placement of Hohn central venous catheters: results and complications in 100 consecutive patientsK L Openshaw, D Picus, M E Hicks, et al.Radiology|April 8, 1998
Recurrent gastrointestinal bleeding: use of thrombolysis with anticoagulation in diagnosisE S Malden, M E Hicks, H D Royal, et al.Current Pharmaceutical Design|June 8, 2002
Antiangiogenic, bioreductive and gene therapy approaches to the treatment of hypoxic tumoursVirginia A McNally, Adam V Patterson, Kaye J Williams, et al.Biochemical Pharmacology|October 24, 2018
Evaluating the abilities of diverse nitroaromatic prodrug metabolites to exit a model Gram negative vector for bacterial-directed enzyme-prodrug therapyJasmine V E Chan-Hyams, Janine N Copp, Jeff B Smaill, et al.Cancer Research|October 3, 2008
Optimized clostridium-directed enzyme prodrug therapy improves the antitumor activity of the novel DNA cross-linking agent PR-104Shie-Chau Liu, G-One Ahn, Mitomu Kioi, et al.Pageof 88